超声子宫输卵管造影检查患者副反应的临床分析
DOI:
CSTR:
作者:
作者单位:

成都医学院第一附属医院超声科

作者简介:

通讯作者:

中图分类号:

基金项目:

四川省卫生厅科研课题(120474)


Clinical analysis on side effects and complications of hysterosalpingocontrastsonography (HyCoSy)Zha xiaoxia, Deng xiaoyang, You lanlan, Zhou jiangying, Wen biao
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    【】目的 评价超声子宫输卵管造影检查患者的副反应情况。方法 通过询问和观察的方法了解超声子宫输卵管造影检查的356例患者发生副反应的类型和程度,并电话随访检查后1个月内的并发症。评价疼痛副反应的程度采用NRS评分法。并分析发生副反应与输卵管梗阻的相关性。结果356例患者中,副反应主要表现为疼痛和迷走神经反应,发生率分别为42.4%(151/356)和9.0%(32/356)。疼痛副反应和迷走神经副反应与输卵管通畅状态均呈正相关(r=0.624,P=0.000<0.01)和(r=0.574,P=0.000<0.01)。并发症主要为检查后持续阴道少量出血(13例)和盆腔感染(1例)。结论 超声子宫输卵管造影检查是安全的,疼痛和迷走神经反应是主要副反应,输卵管梗阻患者尤其易发生,盆腔感染并发症极少。

    Abstract:

    【abstract】Objective To evaluate side effects and complications of hysterosalpingocontrastsonography (HyCoSy). Methods 356 infertile women were examined by HyCoSy and monitored for at least 30 minutes after the procedure. Tolerability to the procedure was evaluated by means of an 11-point numeric rating scale (NRS) of the pain experienced. The statistic differences between side effect and tubal patency were analyzed. Results Of 356 patients, 151 (42.4%) complained obvious pain and 32 (9.0%) experienced mild vasovagal reactions. There was a significant difference on pain experience and vasovagal reactions between patients with patent tubes and those with obstruct tubes. The main late complications were vaginal bleeding for more the 3 days in 13 patients and 1 with acute pelvic phlogosis. Conclusion In our series, HyCoSy was a safe examination; its side effects were pain and vasovagal reactions, which was mainly caused by obstructed tubes. Late complications were very few.

    参考文献
    相似文献
    引证文献
引用本文

查晓霞.超声子宫输卵管造影检查患者副反应的临床分析[J].临床超声医学杂志,2017,19(3):182-185

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-05-05
  • 最后修改日期:2016-06-17
  • 录用日期:2016-07-21
  • 在线发布日期: 2017-04-06
  • 出版日期:
文章二维码

扫码关注

官方微信